share_log

Greenlight Biosciences And Epivax Therapeutics Signed Exclusive Collaboration Agreement To Develop Personalized Cancer Vaccines

Greenlight Biosciences And Epivax Therapeutics Signed Exclusive Collaboration Agreement To Develop Personalized Cancer Vaccines

綠光生物科學與 Epivax 治療學簽署獨家合作協議,開發個人化癌症疫苗
Benzinga Real-time News ·  2023/01/09 07:22

GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA), and EpiVax Therapeutics Inc, today announced that they have signed an exclusive collaboration agreement to jointly develop and commercialize personalized mRNA-based vaccine candidates for cancers.

綠光生物科學控股有限公司(PBC)(NASDAQ:GRNA)和 EpiVAX 治療公司今天宣布,他們已簽署獨家合作協議,共同開發和商業化基於 MRNA 的個性化癌症候選疫苗。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論